Hormonally regulated follicle differentiation and luteinization in the mouse is associated with hypoxia inducible factor activity

Molecular and Cellular Endocrinology

Volumn 327, Issue 1-2, 2010, Pages 47-55

  Tam, Kimberley K Y ^a   Russell, Darryl L ^a   Peet, Daniel J ^b   Bracken, Cameron P ^b   Rodgers, Raymond J ^a   Thompson, Jeremy G ^a   Kind, Karen L ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Follicle; Human chorionic gonadotropin; Hypoxia inducible factor; Ovulation

Indexed keywords

CHORIONIC GONADOTROPIN; ENHANCED GREEN FLUORESCENT PROTEIN; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LUTEINIZING HORMONE; PROGESTERONE; RNA 18S; STEROIDOGENIC ACUTE REGULATORY PROTEIN; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CORPUS LUTEUM; DEVELOPMENTAL STAGE; FEMALE; GENE CONTROL; GRANULOSA CELL; HORMONAL REGULATION; HYPOXIA; IN VIVO STUDY; LUTEINIZATION; MOUSE; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; OVULATION; PRIORITY JOURNAL; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; SIMIAN VIRUS 40; TIME; TRANSGENIC MOUSE;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; CHORIONIC GONADOTROPIN; COBALT; COPULATION; CORPUS LUTEUM; FEMALE; GRANULOSA CELLS; GREEN FLUORESCENT PROTEINS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUTEINIZATION; MICE; MICE, INBRED C57BL; OVARIAN FOLLICLE; OXYGEN; RNA, MESSENGER;

EID: 77955425215     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.06.008     Document Type: Article

References (49)

1. Alam H., Maizels E.T., Park Y., Ghaey S., Feiger Z.J., Chandel N.S., Hunzicker-Dunn M. Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation. J. Biol. Chem. 2004, 279:19431-19440.
2. Bilton R.L., Booker G.W. The subtle side to hypoxia inducible factor (HIFalpha) regulation. Eur. J. Biochem. 2003, 270:791-798.
3. Boonyaprakob U., Gadsby J.E., Hedgpeth V., Routh P.A., Almond G.W. Expression and localization of hypoxia inducible factor-1alpha mRNA in the porcine ovary. Can. J. Vet. Res. 2005, 69:215-222.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
5. Brown J.M., Wilson W.R. Exploiting tumour hypoxia in cancer treatment. Nat. Rev. Cancer 2004, 4:437-447.
6. Bruce N.W., Meyer G.T., Dharmarajan A.M. Rate of blood flow and growth of the corpora lutea of pregnancy and of previous cycles throughout pregnancy in the rat. J. Reprod. Fertil. 1984, 71:445-452.
7. Christenson L.K., Strauss J.F. Steroidogenic acute regulatory protein (StAR) and the intramitochondrial translocation of cholesterol. Biochim. Biophys. Acta 2000, 1529:175-187.
8. Dickson S.E., Bicknell R., Fraser H.M. Mid-luteal angiogenesis and function in the primate is dependent on vascular endothelial growth factor. J. Endocrinol. 2001, 168:409-416.
9. Duncan W.C., van den Driesche S., Fraser H.M. Inhibition of vascular endothelial growth factor in the primate ovary up-regulates hypoxia-inducible factor-1alpha in the follicle and corpus luteum. Endocrinology 2008, 149:3313-3320.
10. Ema M., Taya S., Yokotani N., Sogawa K., Matsuda Y., Fujii-Kuriyama Y. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:4273-4278.
11. Fischer B., Kunzel W., Kleinstein J., Gips H. Oxygen tension in follicular fluid falls with follicle maturation. Eur. J. Obstet. Gynecol. Reprod. Biol. 1992, 43:39-43.
12. Fraser H.M. Regulation of the ovarian follicular vasculature. Reprod. Biol. Endocrinol. 2006, 4:18.
13. Fraser H.M., Duncan W.C. SRB reproduction, fertility and development award lecture 2008. Regulation and manipulation of angiogenesis in the ovary and endometrium. Reprod. Fertil. Dev. 2009, 21:377-392.
14. Fraser H.M., Lunn S.F. Regulation and manipulation of angiogenesis in the primate corpus luteum. Reproduction 2001, 121:355-362.
15. Fraser H.M., Nestor J.J., Vickery B.H. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin. Endocrinology 1987, 121:612-618.
16. Fukuda R., Kelly B., Semenza G.L. Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res. 2003, 63:2330-2334.
17. Gerber S.A., Pober J.S. IFN-alpha induces transcription of hypoxia-inducible factor-1alpha to inhibit proliferation of human endothelial cells. J. Immunol. 2008, 181:1052-1062.
18. Grasselli F., Basini G., Bussolati S., Bianco F. Cobalt chloride, a hypoxia-mimicking agent, modulates redox status and functional parameters of cultured swine granulosa cells. Reprod. Fertil. Dev. 2005, 17:715-720.
19. Greijer A.E., van der Wall E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J. Clin. Pathol. 2004, 57:1009-1014.
20. Hang X., Li P., Li Z., Qu W., Yu Y., Li H., Shen Z., Zheng H., Gao Y., Wu Y., Deng M., Sun Z., Zhang C. Transcription and splicing regulation in human umbilical vein endothelial cells under hypoxic stress conditions by exon array. BMC Genomics 2009, 10:126.
21. Hazzard T.M., Molskness T.A., Chaffin C.L., Stouffer R.L. Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval. Mol. Hum. Reprod. 1999, 5:1115-1121.
22. Herr D., Keck C., Tempfer C., Pietrowski D. Chorionic gonadotropin regulates the transcript level of VHL, p53, and HIF-2alpha in human granulosa lutein cells. Mol. Reprod. Dev. 2004, 69:397-401.
23. Hopfl G., Ogunshola O., Gassmann M. HIFs and tumors - causes and consequences. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 286:R608-623.
24. Hussein M.R. Apoptosis in the ovary: molecular mechanisms. Hum. Reprod. Update 2005, 11:162-177.
25. Ivell R., Bathgate R., Walther N. Luteal peptides and their genes as important markers of ovarian differentiation. J. Reprod. Fertil. Suppl. 1999, 54:207-216.
26. Kim J., Bagchi I.C., Bagchi M.K. Signaling by hypoxia-inducible factors is critical for ovulation in mice. Endocrinology 2009, 150:3392-3400.
27. Kol S., Ben-Shlomo I., Ruutiainen K., Ando M., Davies-Hill T.M., Rohan R.M., Simpson I.A., Adashi E.Y. The midcycle increase in ovarian glucose uptake is associated with enhanced expression of glucose transporter 3. Possible role for interleukin-1, a putative intermediary in the ovulatory process. J. Clin. Invest. 1997, 99:2274-2283.
28. Koos R.D. Increased expression of vascular endothelial growth/permeability factor in the rat ovary following an ovulatory gonadotropin stimulus: potential roles in follicle rupture. Biol. Reprod. 1995, 52:1426-1435.
29. Laitinen M., Ristimaki A., Honkasalo M., Narko K., Paavonen K., Ritvos O. Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells. Endocrinology 1997, 138:4748-4756.
30. Matsuda-Minehata F., Inoue N., Goto Y., Manabe N. The regulation of ovarian granulosa cell death by pro- and anti-apoptotic molecules. J. Reprod. Dev. 2006, 52:695-705.
31. Meyer G.T., Bruce N.W. The cellular pattern of corpus luteal growth during pregnancy in the rat. Anat. Rec. 1979, 193:823-830.
32. Na G., Bridges P.J., Koo Y., Ko C. Role of hypoxia in the regulation of periovulatory EDN2 expression in the mouse. Can. J. Physiol. Pharmacol. 2008, 86:310-319.
33. Neeman M., Abramovitch R., Schiffenbauer Y.S., Tempel C. Regulation of angiogenesis by hypoxic stress: from solid tumours to the ovarian follicle. Int. J. Exp. Pathol. 1997, 78:57-70.
34. Pedersen T., Peters H. Proposal for a classification of oocytes and follicles in the mouse ovary. J. Reprod. Fertil. 1968, 17:555-557.
35. Pham I., Uchida T., Planes C., Ware L.B., Kaner R., Matthay M.A., Clerici C. Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 283:L1133-1142.
36. Pierce J.G., Parsons T.F. Glycoprotein hormones: structure and function. Annu. Rev. Biochem. 1981, 50:465-495.
37. Robker R.L., Russell D.L., Espey L.L., Lydon J.P., O'Malley B.W., Richards J.S. Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:4689-4694.
38. Sanchez-Elsner T., Botella L.M., Velasco B., Corbi A., Attisano L., Bernabeu C. Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J. Biol. Chem. 2001, 276:38527-38535.
39. Semenza G.L. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr. Opin. Genet. Dev. 1998, 8:588-594.
40. Semenza G.L. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med. 2002, 8:S62-S67.
41. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 2003, 3:721-732.
42. Stocco D.M., Clark B.J. Regulation of the acute production of steroids in steroidogenic cells. Endocr. Rev. 1996, 17:221-244.
43. Tapanainen J.S., Lapolt P.S., Perlas E., Hsueh A.J. Induction of ovarian follicle luteinization by recombinant follicle-stimulating hormone. Endocrinology 1993, 133:2875-2880.
44. Tilly J.L. Apoptosis and ovarian function. Rev. Reprod. 1996, 1:162-172.
45. van den Driesche S., Myers M., Gay E., Thong K.J., Duncan W.C. HCG up-regulates hypoxia inducible factor-1 alpha in luteinized granulosa cells: implications for the hormonal regulation of vascular endothelial growth factor A in the human corpus luteum. Mol. Hum. Reprod. 2008, 14:455-464.
46. Wulff C., Dickson S.E., Duncan W.C., Fraser H.M. Angiogenesis in the human corpus luteum: simulated early pregnancy by HCG treatment is associated with both angiogenesis and vessel stabilization. Hum. Reprod. 2001, 16:2515-2524.
47. Zhou J., Bievre M., Bondy C.A. Reduced GLUT1 expression in Igf1-/- null oocytes and follicles. Growth Horm. IGF Res. 2000, 10:111-117.
48. Zimmermann R.C., Hartman T., Bohlen P., Sauer M.V., Kitajewski J. Preovulatory treatment of mice with anti-VEGF receptor 2 antibody inhibits angiogenesis in corpora lutea. Microvasc. Res. 2001, 62:15-25.
49. Zimmermann R.C., Hartman T., Kavic S., Pauli S.A., Bohlen P., Sauer M.V., Kitajewski J. Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development. J. Clin. Invest. 2003, 112:659-669.